The GM Cancer Alliance Early Diagnosis Programme Board (EDPB) is seeking suppliers to assist in a vital initiative aimed at increasing early-stage cancer diagnoses to 75% by 2028. This project will run from 2025 to 2026 and includes several key components: - Engaging with the public and patients to
Contract awarded. Originally published 11 months ago.
Opportunity to design and build a replacement roof for a radiopharmacy facility through all RIBA project stages with full architectural and construction oversight.
Procurement of wigs and accessories with supply and service support for patient use.
Conduct a comprehensive survey of infrastructure backlogs and develop a feasibility study to prioritize and plan implementation of deferred maintenance and improvements.
Installation of new cable ducts to divert around damaged or blocked existing underground ductwork between manhole inspection pits.
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
